Cargando…

Functional changes in human leukemic cell line HL-60. A model for myeloid differentiation

Polar solvents induce terminal differentiation in the human promyelocytic leukemia cell line HL-60. The present studies describe the functional changes that accompany the morphologic progression from promyelocytes to bands and poly-morphonuclear leukocytes (PMN) over 9 d of culture in 1.3 percent di...

Descripción completa

Detalles Bibliográficos
Autores principales: Newburger, PE, Chovaniec, ME, Greenberger, JS, Cohen, HJ
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 1979
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2110469/
https://www.ncbi.nlm.nih.gov/pubmed/225336
_version_ 1782139584517242880
author Newburger, PE
Chovaniec, ME
Greenberger, JS
Cohen, HJ
author_facet Newburger, PE
Chovaniec, ME
Greenberger, JS
Cohen, HJ
author_sort Newburger, PE
collection PubMed
description Polar solvents induce terminal differentiation in the human promyelocytic leukemia cell line HL-60. The present studies describe the functional changes that accompany the morphologic progression from promyelocytes to bands and poly-morphonuclear leukocytes (PMN) over 9 d of culture in 1.3 percent dimethylsulfoxide (DMSO). As the HL-60 cells mature, the rate of O(2-) production increase 18-fold, with a progressive shortening of the lag time required for activation. Hexosemonophosphate shunt activity rises concomitantly. Ingestin of paraffin oil droplets opsonized with complement or Ig increases 10-fold over 9 d in DMSO. Latex ingestion per cell by each morphologic type does not change significantly, but total latex ingestion by groups of cells increases with the rise in the proportion of mature cells with greater ingestion capacities. Degranulation, as measured by release of β-glucuronidase, lysozyme, and peroxidase, reaches maximum after 3-6 d in DMSO, then declines. HL-60 cells contain no detectable lactoferrin, suggesting that their secondary granules are absent or defective. However, they kill staphylococci by day 6 in DMSO. Morphologically immature cells (days 1-3 in DMSO) are capable of O(2-) generation, hexosemonophosphate shunt activity, ingestion, degranulation, and bacterial killing. Maximal performance of each function by cells incubated in DMSO for longer periods of time is 50-100 percent that of normal PMN. DMSO- induced differentiation of HL-60 cells is a promising model for myeloid development.
format Text
id pubmed-2110469
institution National Center for Biotechnology Information
language English
publishDate 1979
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-21104692008-05-01 Functional changes in human leukemic cell line HL-60. A model for myeloid differentiation Newburger, PE Chovaniec, ME Greenberger, JS Cohen, HJ J Cell Biol Articles Polar solvents induce terminal differentiation in the human promyelocytic leukemia cell line HL-60. The present studies describe the functional changes that accompany the morphologic progression from promyelocytes to bands and poly-morphonuclear leukocytes (PMN) over 9 d of culture in 1.3 percent dimethylsulfoxide (DMSO). As the HL-60 cells mature, the rate of O(2-) production increase 18-fold, with a progressive shortening of the lag time required for activation. Hexosemonophosphate shunt activity rises concomitantly. Ingestin of paraffin oil droplets opsonized with complement or Ig increases 10-fold over 9 d in DMSO. Latex ingestion per cell by each morphologic type does not change significantly, but total latex ingestion by groups of cells increases with the rise in the proportion of mature cells with greater ingestion capacities. Degranulation, as measured by release of β-glucuronidase, lysozyme, and peroxidase, reaches maximum after 3-6 d in DMSO, then declines. HL-60 cells contain no detectable lactoferrin, suggesting that their secondary granules are absent or defective. However, they kill staphylococci by day 6 in DMSO. Morphologically immature cells (days 1-3 in DMSO) are capable of O(2-) generation, hexosemonophosphate shunt activity, ingestion, degranulation, and bacterial killing. Maximal performance of each function by cells incubated in DMSO for longer periods of time is 50-100 percent that of normal PMN. DMSO- induced differentiation of HL-60 cells is a promising model for myeloid development. The Rockefeller University Press 1979-08-01 /pmc/articles/PMC2110469/ /pubmed/225336 Text en This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Articles
Newburger, PE
Chovaniec, ME
Greenberger, JS
Cohen, HJ
Functional changes in human leukemic cell line HL-60. A model for myeloid differentiation
title Functional changes in human leukemic cell line HL-60. A model for myeloid differentiation
title_full Functional changes in human leukemic cell line HL-60. A model for myeloid differentiation
title_fullStr Functional changes in human leukemic cell line HL-60. A model for myeloid differentiation
title_full_unstemmed Functional changes in human leukemic cell line HL-60. A model for myeloid differentiation
title_short Functional changes in human leukemic cell line HL-60. A model for myeloid differentiation
title_sort functional changes in human leukemic cell line hl-60. a model for myeloid differentiation
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2110469/
https://www.ncbi.nlm.nih.gov/pubmed/225336
work_keys_str_mv AT newburgerpe functionalchangesinhumanleukemiccelllinehl60amodelformyeloiddifferentiation
AT chovaniecme functionalchangesinhumanleukemiccelllinehl60amodelformyeloiddifferentiation
AT greenbergerjs functionalchangesinhumanleukemiccelllinehl60amodelformyeloiddifferentiation
AT cohenhj functionalchangesinhumanleukemiccelllinehl60amodelformyeloiddifferentiation